|
ARHGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.70759999993531E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00830000000041E-05 |
| Normal-vs-Stage2 |
1.059700E-02 |
| Normal-vs-Stage3 |
9.93559999999949E-05 |
| Normal-vs-Stage4 |
3.02009999997299E-06 |
| Stage1-vs-Stage2 |
9.600800E-01 |
| Stage1-vs-Stage3 |
5.928400E-01 |
| Stage1-vs-Stage4 |
1.102600E-01 |
| Stage2-vs-Stage3 |
7.130800E-01 |
| Stage2-vs-Stage4 |
2.362400E-01 |
| Stage3-vs-Stage4 |
3.172000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.9048000045081E-08 |
| Normal-vs-AfricanAmerican |
3.636000E-04 |
| Normal-vs-Asian |
6.780300E-04 |
| Caucasian-vs-AfricanAmerican |
9.347400E-01 |
| Caucasian-vs-Asian |
5.005400E-01 |
| AfricanAmerican-vs-Asian |
5.436400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61599999998408E-06 |
| Normal-vs-Female |
3.973200000007E-06 |
| Male-vs-Female |
2.978000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.05270000003455E-06 |
| Normal-vs-Age(41-60Yrs) |
1.79710000003386E-06 |
| Normal-vs-Age(61-80Yrs) |
1.937550E-03 |
| Normal-vs-Age(81-100Yrs) |
3.562800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.252000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.238600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.254000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.760400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.100800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.565800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.325600E-01 |
| Classical-VS-Follicular |
1.67110769666579E-12 |
| Classical-VS-Other |
9.557900E-02 |
| Classical-VS-Normal |
7.86470000235795E-10 |
| Tall-VS-Follicular |
1.6253699999913E-05 |
| Tall-VS-Other |
1.116230E-01 |
| Tall-VS-Normal |
1.982200E-04 |
| Follicular-VS-Other |
4.869000E-01 |
| Follicular-VS-Normal |
6.407600E-01 |
| Other-VS-Normal |
5.463800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.401700E-04 |
| Normal-vs-N1 |
2.722400E-02 |
| N0-vs-N1 |
8.735400E-01 |
|
|
